SCHEMBL7463560

SCHEMBL7463560

COCc1cc2ccc(C(=O)OC)cc2n1C(=O)OCc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APOBEC3A P31941 1/20 0.43
APOBEC3G Q9HC16 1/20 0.43
LMNA P02545 3/20 0.43
HPGD P15428 2/20 0.43
RAB9A P51151 6/20 0.41
MAPT P10636 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 1/20 0.41
PKM P14618 1/20 0.40
NPC1 O15118 2/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
KMT2A Q03164 2/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A3 Q01959 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ACSS2 Q9NR19 1/20 0.39
PTGDR2 Q9Y5Y4 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7417793 0.91 APOBEC3A (0.45) APOBEC3AAPOBEC3GLMNAHPGDRAB9A
SCHEMBL7423925 0.89 APOBEC3A (0.44) APOBEC3AAPOBEC3GLMNAHPGDRAB9A
SCHEMBL7420108 0.88 APOBEC3A (0.41) APOBEC3AAPOBEC3GLMNAHPGDRAB9A
SCHEMBL7418955 0.86 APOBEC3A (0.44) APOBEC3AAPOBEC3GLMNAHPGDRAB9A
SCHEMBL7166718 0.76 LMNA (0.45) LMNAHPGDRAB9AMAPTSMN1; SMN2
SCHEMBL7214021 0.76 PARP1 (0.44) APOBEC3AAPOBEC3GLMNAHPGDRAB9A
SCHEMBL28460969 0.74 KDM1A (0.47) RAB9ASMN1; SMN2ALDH1A1NPC1KMT2A
Ammonia Solution, Strong SCHEMBL27457140 0.73 KMT2A (0.57) LMNAHPGDRAB9AMAPTSMN1; SMN2
SCHEMBL15294682 0.72 EHMT2 (0.48) LMNAHPGDRAB9AMAPTSMN1; SMN2
SCHEMBL15687343 0.72 MTNR1A (0.50) APOBEC3AAPOBEC3GHPGDMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed